Gepotidacin: all 23 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenRecruitingNCT07645235Phase 1
• A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis AntibioticsNot yet recruitingNCT07371429Phase 1
• A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)CompletedNCT06597344Phase 3Results posted
• A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)CompletedNCT05630833Phase 3Results posted
• Drug-drug Interaction Study of GepotidacinCompletedNCT04493931Phase 1Results posted
• Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)CompletedNCT04187144Phase 3Results posted
• Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents SubjectsCompletedNCT04079790Phase 1Results posted
• A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)CompletedNCT04020341Phase 3Results posted
• A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital GonorrheaCompletedNCT04010539Phase 3Results posted
• Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)CompletedNCT03568942Phase 2Results posted
• Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic FunctionCompletedNCT03562117Phase 1Results posted
• To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.CompletedNCT02853435Phase 1Results posted
• Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal FunctionCompletedNCT02729038Phase 1Results posted
• A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria GonorrhoeaeCompletedNCT02294682Phase 2Results posted
• Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT02045797Phase 2Results posted
• A Study to Evaluate Pharmacokinetic, Safety, Tolerability and Relative Bioavailability of Gepotidacin in Healthy Adult Male and Female ParticipantsCompletedNCT05271799Phase 1
• Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar TissueCompletedNCT04484740Phase 1
• Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy VolunteersCompletedNCT02257398Phase 1
• A Single Oral Escalating Dose Study of GSK2140944 in Healthy VolunteersCompletedNCT02202187Phase 1
• Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy SubjectsCompletedNCT02045849Phase 1
• A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male SubjectsCompletedNCT02000765Phase 1
• To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944CompletedNCT01934205Phase 1
• This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult SubjectsCompletedNCT01706315Phase 1

← Gepotidacin overview